Literature DB >> 15100296

The mouse homologue of the leukocyte-associated Ig-like receptor-1 is an inhibitory receptor that recruits Src homology region 2-containing protein tyrosine phosphatase (SHP)-2, but not SHP-1.

Robert Jan Lebbink1, Talitha de Ruiter, Annelies Verbrugge, Wendy S Bril, Linde Meyaard.   

Abstract

We report the molecular cloning and characterization of the first leukocyte-associated Ig-like receptor 1 (LAIR-1) homologue in mice that we have named mouse LAIR-1 (mLAIR-1). The mLAIR-1 gene maps to the proximal end of mouse chromosome 7 in a region syntenic with human chromosome 19q13.4 where the leukocyte receptor cluster is located. The protein shares 40% sequence identity with human LAIR-1, has a single Ig-like domain, and contains two immunoreceptor tyrosine-based inhibitory motif-like structures in its cytoplasmic tail. Mouse LAIR-1 is broadly expressed on various immune cells, and cross-linking of the molecule on stably transfected RBL-2H3 and YT.2C2 cells results in strong inhibition of their degranulation and cytotoxic activities, respectively. Upon pervanadate stimulation, the mLAIR-1 cytoplasmic tail becomes phosphorylated, thereby recruiting Src homology region 2-containing tyrosine phosphatase-2. Interestingly, unlike human LAIR-1, Src homology region 2-containing tyrosine phosphatase-1 is not recruited to the mLAIR-1 cytoplasmic tail. Screening human and mouse cell lines for mLAIR-1 and human LAIR-1 binding partners identified several lines expressing putative ligand(s) for both receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100296     DOI: 10.4049/jimmunol.172.9.5535

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Paired immunoglobulin-like receptors and their MHC class I recognition.

Authors:  Toshiyuki Takai
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

2.  Post-translational modification of type IV collagen with 3-hydroxyproline affects its interactions with glycoprotein VI and nidogens 1 and 2.

Authors:  Nathan T Montgomery; Keith D Zientek; Elena N Pokidysheva; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2018-02-28       Impact factor: 5.157

3.  Identification and characterization of the rat homologue of LAIR-1.

Authors:  Robert Jan Lebbink; Talitha de Ruiter; Guido J A Kaptijn; Linde Meyaard
Journal:  Immunogenetics       Date:  2005-05-18       Impact factor: 2.846

4.  Leukocyte-associated Ig-like receptor-1-deficient mice have an altered immune cell phenotype.

Authors:  Xiaobin Tang; Linjie Tian; Gloria Esteso; Seung-Chul Choi; Alexander D Barrow; Marco Colonna; Francisco Borrego; John E Coligan
Journal:  J Immunol       Date:  2011-12-07       Impact factor: 5.422

Review 5.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

6.  Leucocyte-associated immunoglobulin-like receptor-1 is an inhibitory regulator of contact hypersensitivity.

Authors:  Ryusuke Omiya; Fumihiko Tsushima; Hidehiko Narazaki; Yukimi Sakoda; Atsuo Kuramasu; Youn Kim; Haiying Xu; Hideto Tamura; Gefeng Zhu; Lieping Chen; Koji Tamada
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

7.  A single residue, arginine 65, is critical for the functional interaction of leukocyte-associated inhibitory receptor-1 with collagens.

Authors:  Xiaobin Tang; Sriram Narayanan; Giovanna Peruzzi; Akintomide Apara; Kannan Natarajan; David H Margulies; John E Coligan; Francisco Borrego
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

8.  IL-7-induced phosphorylation of the adaptor Crk-like and other targets.

Authors:  Francesca B Aiello; Tad Guszczynski; Wenqing Li; Julie A Hixon; Qiong Jiang; Deborah L Hodge; Tania Massignan; Chiara Di Lisio; Anand Merchant; Antonio D Procopio; Valentina Bonetto; Scott K Durum
Journal:  Cell Signal       Date:  2018-03-24       Impact factor: 4.315

Review 9.  Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy.

Authors:  Anna Śledzińska; Laurie Menger; Katharina Bergerhoff; Karl S Peggs; Sergio A Quezada
Journal:  Mol Oncol       Date:  2015-10-26       Impact factor: 6.603

10.  PAG/Cbp suppression reveals a contribution of CTLA-4 to setting the activation threshold in T cells.

Authors:  Michal Smida; Clemens Cammann; Slavyana Gurbiel; Nadja Kerstin; Holger Lingel; Sabine Lindquist; Luca Simeoni; Monika C Brunner-Weinzierl; Miloslav Suchanek; Burkhart Schraven; Jonathan A Lindquist
Journal:  Cell Commun Signal       Date:  2013-04-19       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.